Viokace Market Report 2026

Viokace Market Overview

• The Viokace market growth in the historic period has been driven by increasing diagnosis of exocrine pancreatic insufficiency, rising prevalence of chronic pancreatitis • Market expansion is supported by increasing demand for long-term digestive support therapies, expansion of personalized dosing regimens • Growth Driver: Surge In Prevalence Of Pancreatic Disorders Driving Market Growth Due To Rising Demand For Pancreatic Enzyme Replacement Therapy • North America was the largest region in 2025.

What Is Covered Under Viokace Market?

Viokace is a prescription medication containing pancrelipase, an enzyme replacement therapy used to treat exocrine pancreatic insufficiency (EPI) in individuals with conditions such as chronic pancreatitis or cystic fibrosis. It helps in the digestion of food by supplementing the body's natural pancreatic enzymes, improving nutrient absorption and reducing symptoms such as malabsorption and weight loss. The main types of indications for viokace are exocrine pancreatic insufficiency, chronic pancreatitis, and other pancreatic disorders. Exocrine pancreatic insufficiency (EPI) is a condition where the pancreas fails to produce enough digestive enzymes, leading to difficulty in digesting food and absorbing nutrients. They are distributed through various distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and it is used by several end users, including adults and geriatric patients.

What Is The Viokace Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for long-term digestive support therapies, expansion of personalized dosing regimens, growing geriatric population with digestive disorders, rising focus on nutrition optimization, increasing access to specialty gastrointestinal treatments. Major trends in the forecast period include increasing use of enzyme replacement therapies, rising focus on digestive disorder management, growing adoption of pancreatic enzyme supplements, expansion of chronic pancreatitis treatment protocols, enhanced patient adherence support.

Global Viokace Market Segmentation

1) By Indication: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis, Other Pancreatic Disorders 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By End User: Adult, Geriatric

What Are The Drivers Of The Viokace Market?

The increasing prevalence of pancreatic disorders is expected to propel the growth of the viokace market going forward. Pancreatic disorders refer to a range of medical conditions that affect the pancreas, an organ responsible for producing digestive enzymes and hormones such as insulin. The rising prevalence of pancreatic disorders can be attributed to factors such as an aging population, unhealthy lifestyle choices, increasing rates of obesity, and the growing incidence of diseases like diabetes, which can affect pancreatic function. Viokace helps manage pancreatic disorders by providing digestive enzymes that assist in the breakdown of fats, proteins, and carbohydrates, which is essential for individuals with conditions like chronic pancreatitis or cystic fibrosis, where the pancreas fails to secrete sufficient enzymes for proper digestion and nutrient absorption. For instance, in February 2023, according to Cancer Research UK, a UK-based independent cancer research organization, the incidence rates of pancreatic cancer in the UK are expected to increase by 5% between the periods of 2023-2025 and 2038-2040, reaching an average of 19 cases per 100,000 people annually by 2038-2040. Therefore, the increasing prevalence of pancreatic disorders is driving the growth of the viokace industry. The increasing geriatric population is set to propel the growth of the viokace market moving forward. The geriatric population typically refers to older adults, usually aged 65 and over, who often face unique health, social, and economic challenges. The increasing geriatric population is primarily due to advancements in healthcare, leading to longer life expectancy and declining birth rates. Viokace helps the geriatric population by providing essential pancreatic enzymes that improve digestion and nutrient absorption in older adults who may experience pancreatic insufficiency due to aging-related conditions such as chronic pancreatitis or other pancreatic disorders, thereby enhancing their overall digestive health and quality of life. For instance, in 2024, according to United Nations Department of Economic and Social Affairs, a US-based United Nations department, in 2023, 10 of today’s least developed countries had more than 1 million older persons and by 2050 this number is projected to increase to 27, including 2 countries with more than 10 million older persons. Therefore, the increasing geriatric population is driving the growth of the viokace industry. Rising healthcare expenditure is expected to propel the growth of the viokace market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare services, including medical treatments, equipment, infrastructure, and personnel, by governments, individuals, and private entities. Rising healthcare expenditure is due to factors such as an aging population, increased prevalence of chronic diseases, advancements in medical technology, and the growing demand for better healthcare services. Rising healthcare expenditure improves access to advanced treatments like viokace by increasing affordability and availability through better healthcare infrastructure and reimbursement policies. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms from 2022 to 2023, marking a significant acceleration compared to the 0.9% growth observed in 2022. Therefore, rising healthcare expenditure is driving the growth of the viokace industry.

Key Players In The Global Viokace Market

Major companies operating in the viokace market are AbbVie Inc.

Regional Insights

North America was the largest region in the viokace market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Viokace Market?

The viokace market consists of sales of pharmaceutical products, diagnostic reagents, and medical devices. This market also encompasses associated costs for distribution, healthcare professional services, and patient support programs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viokace Market Report 2026?

The viokace market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viokace industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.